J
% 5 Best Cannabis Stocks to Buy in 2022 Skip to content
visibility
364 views
thumb_up
12 likes
R
Explore
Manage Money
You've got it. Learn what to do with it.
thumb_up
36 likes
J
Explore
Save Money
You have it. Make sure you have some later too.
thumb_up
35 likes
A
Explore
Spend Money
You're spending it. Get the most for it.
thumb_up
47 likes
H
Explore
Borrow Money
You're borrowing it. Do it wisely. ExploreProtect Money
You don't want to lose it.
thumb_up
41 likes
E
Learn how to keep it safe. Explore
Invest Money
You're saving it. Now put it to work for your future.
thumb_up
10 likes
M
Explore
Categories
About us
Find us
Close menuWhat do you want to do br with money
Popular Searches
Learn more about your money
Make Money
You need it. Learn how to make it.
thumb_up
33 likes
L
Explore
Manage Money
You've got it. Learn what to do with it.
thumb_up
14 likes
C
Explore
Save Money
You have it. Make sure you have some later too.
thumb_up
14 likes
L
Explore
Spend Money
You're spending it. Get the most for it.
thumb_up
21 likes
H
Explore
Borrow Money
You're borrowing it. Do it wisely. ExploreProtect Money
You don't want to lose it.
thumb_up
47 likes
H
Learn how to keep it safe. Explore
Invest Money
You're saving it.
thumb_up
36 likes
M
Now put it to work for your future. Explore
Categories
About us
Find us
Close menu Advertiser Disclosure Advertiser Disclosure: The credit card and banking offers that appear on this site are from credit card companies and banks from which MoneyCrashers.com receives compensation.
thumb_up
5 likes
N
This compensation may impact how and where products appear on this site, including, for example, the order in which they appear on category pages. MoneyCrashers.com does not include all banks, credit card companies or all available credit card offers, although best efforts are made to include a comprehensive list of offers regardless of compensation. Advertiser partners include American Express, Chase, U.S.
thumb_up
40 likes
M
Bank, and Barclaycard, among others. Invest Money Stocks
5 Best Cannabis Stocks to Buy in 2022
By Joshua Rodriguez Date January 10, 2022FEATURED PROMOTION
On October 17, 2018, Canada legalized cannabis for adult use.
thumb_up
6 likes
J
Since the debate leading to this legalization started, cannabis stocks have been all the rage. An entirely new market is emerging, and investors want to get involved early.
thumb_up
29 likes
C
Investors have been so excited about cannabis stocks that we saw a bubble in the sector leading up to the rise of adult-use marijuana in Canada. Since then, the bubble has popped and stock values have come back to reality. Now there’s a strong argument that the marijuana market is poised for a rebound.
thumb_up
45 likes
M
In particular, there’s a strong argument that with Joe Biden as president and the Democratic Party controlling both the Senate and the House, cannabis could soon be legal for adult use in the United States as well. In anticipation of this possibility, investors are eyeing the top cannabis stocks yet again. With the cannabis sector in its infancy, there’s no doubt the companies that worked hard to take control early on will become the leaders of the industry in the future.
thumb_up
38 likes
E
Getting in on these early cannabis market leaders offers a substantial opportunity for long-term stock market gains.
You own shares of Apple, Amazon, Tesla. Why not Banksy or Andy Warhol?
You own shares of Apple, Amazon, Tesla. Why not Banksy or Andy Warhol?
thumb_up
19 likes
C
Their works’ value doesn’t rise and fall with the stock market. And they’re a lot cooler than Jeff Bezos.
Get Priority Access Pro tip: You can earn up to a $2,500 bonus when you open and fund a new trading account from M1 Finance.
Get Priority Access Pro tip: You can earn up to a $2,500 bonus when you open and fund a new trading account from M1 Finance.
thumb_up
7 likes
L
With M1 Finance, you can customize your portfolio with stocks and ETFs, plus you can invest in fractional shares. Sign up for M1 Finance.
thumb_up
24 likes
D
5 Best Cannabis Stocks to Buy
When investing in emerging sectors, including investments in both recreational and medical marijuana stocks, it’s as important as ever to make the right moves in the market. Any company with a remote similarity to companies within the sector will try to get involved. Due to market uncertainty and capital issues, many of the penny stocks in the marijuana industry will fail.
thumb_up
49 likes
L
Nonetheless, where there’s risk, there’s generally reward. Making the right investments in a sector’s infancy can lead to vast long-run profits.
thumb_up
48 likes
D
If you’re thinking about investing in the cannabis industry and sharing in these potential long-term profits, the pot stocks below are a great place to start your research.
1 GW Pharmaceuticals NASDAQ GWPH
Investing in an emerging sector involves quite a bit of speculation, so it’s best to look for investments that hedge these bets.
thumb_up
29 likes
N
Due to the regulatory concerns associated with cannabis, pot stocks are higher-risk than investments in other, less regulated industries. GW Pharmaceuticals gives investors an interesting way to get involved in the cannabis market while bypassing the debate over legal recreational-use marijuana. The company isn’t interested in growing cannabis or catering to the adult-use cannabis sector.
thumb_up
42 likes
Z
Instead, GW Pharmaceuticals uses cannabinoids derived from the cannabis plant as key ingredients in the development of new therapeutic options, bringing medical marijuana to the next level. GW Pharmaceuticals’ claim to fame is a treatment known as Epidiolex.
thumb_up
6 likes
C
The treatment is a highly-refined form of cannabidiol, or CBD, that was developed as a treatment for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in younger patients ages two and older. It is also the product that gives GW Pharmaceuticals the crown as the first biotech company to receive U.S.
thumb_up
32 likes
D
approval for a cannabis-related drug. Because Epidiolex has proven to be far more effective than standard-of-care therapies like clobazam and valproic acid while greatly reducing side effects in its target patient population, the treatment has seen incredible adoption rates in the space.
thumb_up
43 likes
J
The growing sales of the drug are a driving force behind the company’s compelling year-over-year revenue growth, which clocked in at about 69% in 2020. The company generated $527.2 million in overall revenue in 2020, more than $510 million of which was attributed directly to sales of Epidiolex.
thumb_up
0 likes
A
Guidance for the full year 2021 suggests that the company will generate more than $3 billion in overall revenue with Epidiolex leading the charge once again. GW Pharmaceuticals is also a prime beneficiary of the United States Farm Bill passed in December 2018. This bill reclassified CBD products and hemp, separating them from cannabis, which remains a Schedule I substance controlled by the Drug Enforcement Administration in the United States.
thumb_up
10 likes
B
With CBD being the main ingredient in Epidiolex, GW Pharmaceuticals will benefit from reduced costs and increased accessibility, ultimately assisting the company in margin growth moving forward. The company is by no means a one-trick pony.
thumb_up
44 likes
I
GW is currently in the late stages of development of a treatment known as Sativex, another cannabis-based therapeutic option. This treatment centers around the use of cannabis extracts THC and CBD as potential options for patients with multiple sclerosis (MS). Should this treatment be approved, it has a strong chance of becoming yet another blockbuster and major revenue driver for the company.
thumb_up
40 likes
L
At the moment, GW Pharmaceuticals is in the midst of late-stage clinical trials to bring Salivex to market. Beyond Epidiolex and Sativex, the company has two other cannabis-based clinical candidates that are the subject of four clinical development programs.
thumb_up
25 likes
A
With multiple clinical development programs currently underway, revenue growing at a breakneck speed, and Sativex being on the verge of reaching the market, GWPH is one for the watchlist. Pro tip: If you sign up for Motley Fool Stock Advisor you’ll receive their free report, “One Stock for the Cannabis Boom.”
2 Cronos Group NASDAQ CRON
Cronos Group operates on the opposite end of the cannabis market from GW Pharmaceuticals. The company is focused on recreational cannabis and has quickly become one of the biggest companies in the marijuana market.
thumb_up
44 likes
L
A major part of the company’s growth has to do with an investment made by American tobacco company Altria. The maker of Marlboro, Parliament, and Virginia Slims cigarettes saw value in the cannabis industry early and saw Cronos Group as one of the best marijuana stocks on the market.
thumb_up
21 likes
L
In late 2018, Altria invested $1.8 billion into Cronos stock, bolstering what has become one of the most impressive balance sheets in the cannabis space. This may be surprising, considering that Cronos only generates between $300 and $400 million in revenue per year. So, what did Altria find interesting enough about the company to make a $1.8 billion investment in a comparatively small marijuana company?
thumb_up
40 likes
C
Cronos Group is one of the key cannabis growers in Canada, helping to support the country’s booming cannabis business. However, that’s just one part of the company’s work. The company is also actively involved in penetrating other markets around the world.
thumb_up
32 likes
W
The biggest of these markets is the United States, and tapping into this market has the potential to lead to skyrocketing valuations. At the moment, there are only six states in the U.S.
thumb_up
22 likes
L
that have not decriminalized or legalized cannabis in some way. Although marijuana is still illegal on the federal level, the push from state to state to decriminalize or legalize the plant suggests that federal legalization of adult-use cannabis will come down the line sooner rather than later. In fact, a bill is expected to be filed shortly to do just that, according to Marijuana Moment.
thumb_up
18 likes
S
Cronos Group is uniquely positioned to capitalize on the potential legalization of cannabis in the U.S. Given the company’s success in the Canadian market, similar success in the United States market would drive far higher revenues on account of the much larger size of the U.S.
thumb_up
2 likes
R
economy. All Cronos would need to take the U.S. market by storm is a strong partner that can guide the company through the unique regulatory environment in the region.
thumb_up
36 likes
A
The Altria investment in Cronos Group turned out to be a match made in heaven. If and when cannabis becomes legal in the United States, Cronos has the ability to grow enough of the product to meet demand. And, as a big tobacco player in the U.S., Altria group understands marketing, manufacturing, and sales of highly regulated products in the region.
thumb_up
6 likes
C
Between the two, the potential for complete U.S. marijuana-market dominance is there.
thumb_up
31 likes
A
Cronos is a highly speculative play. Much of the value of the investment lies in the United States legalizing cannabis for adult use over the next few years, a promising prospect considering the results of the 2020 election season. Should this take place, the potential for gains is hard to ignore, making Cronos one of the top stocks in the cannabis market and one that’s well worth watching.
thumb_up
18 likes
C
3 Innovative Industrial Properties Inc NYSE IIPR
Cannabis has several subsectors. There are growers, dispensaries, health care companies, and companies that support and supply them, all working together to build the cannabis ecosystem. A major part of that ecosystem is physical space.
thumb_up
7 likes
J
After all, in order to operate a cannabis growing operation that produces enough of the flower to generate a meaningful profit, or to operate a manufacturer that processes the plant into end products at scale, these companies need room to work. They need real estate.
thumb_up
18 likes
C
That’s where Innovative Industrial Properties comes in. The stock represents a real estate investment trust, or REIT, but it’s like no other REIT on the market today.
thumb_up
12 likes
S
It’s the first company listed on the New York Stock Exchange that provides real estate capital to the booming U.S. medical marijuana industry.
thumb_up
37 likes
N
As a REIT, the company uses investments provided by a large number of investors to acquire income-generating properties. However, the company isn’t buying apartment buildings or strip malls. Instead, it invests in massive real estate specifically designed for use as indoor cannabis grow rooms.
thumb_up
15 likes
H
These properties are then rented to growers, and the profits from the rent are shared with investors. The company kicks back at least 90% of its profits to its investors by way of dividends, making it a great option for the income investor looking for exposure to the cannabis sector. However, the stock doesn’t move like any income stock you’ve ever seen.
thumb_up
7 likes
N
Over the past year, it’s grown from about $125 per share to more than $225 per share, making it an attractive option for growth investors as well. No matter how you slice it, IIPR stock is one that’s hard to ignore.
thumb_up
48 likes
A
The company’s business model is clearly working as it continues to pay investors meaningful dividends, and with the growth in the price of the stock over the past year, there’s not an investor without a smile from ear to ear. All in all, this stock is one to watch closely.
thumb_up
25 likes
E
Pro tip: Before you add any cannabis stocks to your portfolio, make sure you’re choosing the best possible companies. Stock screeners like Trade Ideas can help you narrow down the choices to companies that meet your individual requirements. Learn more about our favorite stock screeners.
4 Canopy Growth Corporation NYSE CGC
Canopy Growth Corporation has quickly made a name for itself.
thumb_up
46 likes
O
The company is among the top three cannabis companies in the world by market cap and has become the largest cannabis producer in the world, according to Zippia. That’s nothing to shake a stick at. Like Cronos Group, Canopy has also attracted high-dollar investor interest from a U.S.
thumb_up
21 likes
Z
company operating in a heavily regulated market. Constellation Brands, best known for its alcoholic beverage brands like Corona, Modelo, and Casa Noble, made a $4 billion investment in the company in August 2018.
thumb_up
42 likes
A
As a result, Canopy Growth Corporation’s balance sheet is at least as impressive as that of Cronos Group, ranking as one of the top two best balance sheets in the cannabis space. As with much of the sector, Canopy saw widening losses and reductions in overall revenue in its second-quarter fiscal 2021 financial results.
thumb_up
14 likes
C
However, the company bounced back in the third quarter, producing 23% year-over-year revenue growth, largely driven by a rebound in domestic recreational cannabis demand as well as international medical demand. There’s a strong argument that while it has begun to recover from weakness relating to coronavirus blues, the stock remains vastly undervalued, leaving further room for growth. Moreover, analysts are expecting a strong recovery, which pairs well with the idea that Canopy Growth is highly undervalued.
thumb_up
36 likes
S
As a long-term play, Canopy may be one of the best cannabis-related stocks on the market today. It may take the company some time to reach profitability following recent revenue declines, but it can afford to wait.
thumb_up
49 likes
M
The company has multiple billions of dollars in cash and is in the process of using some of this cash to acquire smaller companies and assets, setting the stage for strong revenue growth as COVID-19 comes to an end and further regulatory changes take place around the world. When a market is in its infancy, companies that work hard to take control of the industry will generally become its long-term leaders.
thumb_up
43 likes
M
That’s exactly what Canopy Growth Corporation is doing. With such a strong financial position, the company is setting profitability on the back burner and focusing on building up its assets to a point where no other company in the space will be big enough to compete.
thumb_up
10 likes
S
This is the same type of play made by Amazon.com early on. The company hemorrhaged money to build infrastructure and create a better user experience.
thumb_up
15 likes
L
Many wondered if the company would ever turn a profit. Today, Amazon.com is one of the most profitable retailers in the world, and there’s no sign of the company’s growth slowing.
thumb_up
33 likes
H
Canopy Growth is in a similar position. It’s got the money to spend, and it plans on doing so in order to build the potential for extreme long-run value.
thumb_up
3 likes
E
That makes this stock one that’s worth considering diving into.
5 Tilray Inc NASDAQ TLRY
Tilray was already one of the largest Canadian cannabis growers in early 2021 However, thanks to a merger with Aphria that closed in the first half of 2021, the company has become the largest cannabis grower in the world, according to Forbes.
thumb_up
32 likes
O
While the stock was an interesting play in the past, the merger with Aphria made it impossible to ignore. In most cases, when a new market is born, it’s highly fragmented with several small companies that make up the overall emerging sector.
thumb_up
30 likes
K
As a market matures, consolidation — or the combination of these fragmented pieces into larger, merged companies — is important not just to determine who will be the market leader, but for the strength and survival of the sector as a whole. Through consolidation, larger players are able to reduce the cost of production of goods, resulting in higher margins for companies and a lower overall cost for consumers. Tilray has been doing just that for quite some time now.
thumb_up
10 likes
L
It’s the proud parent company of High Park Holdings, Fresh Hemp Foods, Smith & Sinclair, and several other subsidiaries, but none of these smaller subsidiaries hold a candle to Aphria, which is one of the largest cannabis producers in the world. The combination of these two companies brings the consolidation of a fragmented market to a whole new level.
thumb_up
41 likes
K
This is a strong play that happened at an interesting time. The COVID-19 pandemic has been painful for the marijuana sector as a whole. Lockdowns led to tremendous reductions in revenue and painful declines for many.
thumb_up
17 likes
C
The times are changing. Today, multiple vaccines are on the market, and many expect the COVID-19 pandemic to be behind us relatively soon. Tilray plans to capitalize on the recovery with its scalable operational footprint and diverse portfolio of cannabis products.
thumb_up
11 likes
J
By working to consolidate the cannabis market, Tilray has become the largest cannabis producer in the world, and as the world reopens following one of the worst health care crises in modern history, the company is poised for significant growth ahead.
Final Word
The cannabis sector is an exciting one.
thumb_up
24 likes
R
Led by speculation that nations like the United States will soon break down regulatory barriers in the industry, investing dollars are being poured into the space. Before you throw your dollars in the ring, it’s important to do your research and consider the risks. Most companies in the cannabis space are not profitable.
thumb_up
0 likes
J
If they don’t have a strong enough balance sheet, this could mean that there will be transactions in the company’s near future that aren’t in the best interest of investors. Furthermore, because much of the value in cannabis stocks is a predetermination banking on the idea that the U.S.
thumb_up
23 likes
L
will legalize the drug, regulatory headwinds could result in sector-wide losses. However, if all goes well, the cannabis industry could soon be a booming one with the potential to create tens of billions of dollars in revenue for the companies that take part. Disclaimer: The author currently has no positions in any stock mentioned herein nor any intention to hold any positions within the next 72 hours.
thumb_up
6 likes
Z
The views expressed are those of the author of the article and not necessarily those of other members of the Money Crashers team or Money Crashers as a whole. This article was written by Joshua Rodriguez, who shared his honest opinion of the companies mentioned.
thumb_up
46 likes
A
However, this article should not be viewed as a solicitation to purchase shares in any security and should only be used for entertainment and informational purposes. Investors should consult a financial advisor or do their own due diligence before making any investment decision.
thumb_up
27 likes
C
Stocks Invest Money TwitterFacebookPinterestLinkedInEmail
Joshua Rodriguez
Joshua Rodriguez has worked in the finance and investing industry for more than a decade. In 2012, he decided he was ready to break free from the 9 to 5 rat race. By 2013, he became his own boss and hasn’t looked back since.
thumb_up
42 likes
A
Today, Joshua enjoys sharing his experience and expertise with up and comers to help enrich the financial lives of the masses rather than fuel the ongoing economic divide. When he’s not writing, helping up and comers in the freelance industry, and making his own investments and wise financial decisions, Joshua enjoys spending time with his wife, son, daughter, and eight large breed dogs. See what Joshua is up to by following his Twitter or contact him through his website, CNA Finance.
thumb_up
39 likes
D
FEATURED PROMOTION
Discover MoreRelated Articles
Stocks See all Economy & Policy Should the Federal Government Legalize Marijuana? - Pros & Cons Stocks How to Invest During a Stock Market Bubble and Cash in Before It Pops Stocks Over-the-Counter (OTC) Stocks - What They Are & Why You Should Invest Stocks How to Invest in Emerging Market Stocks - Tips for Getting Started Related topicsWe answer your toughest questions
See more questions Invest MoneyShould I invest in cannabis stocks
See the full answer » StocksWhat are cannabis stocks and why should I invest in them
See the full answer »
thumb_up
30 likes
Similar Discussions
-
Girl you re overreacting Married at First Sight fans slam Morgan for fighting with Binh over sharing personal details about his marriage
-
Neuropathy Signs Symptoms and Diagnosis Everyday Health
-
All the Midnight Club Book Spoilers You Need Explained
-
Internet Download Manager aka IDM Review Should You Buy It?
-
GBF Toolbox APK Download for Android APKfun com
-
B3 ACADEMY APK Download for Android
-
Opinion Only Class Struggle Can Save the Left
-
How to Access Samsung Notes On a PC
-
Why Do Apple Devices Have All These Weird Chargers
-
Compare Ford F 450 Super Duty vs 2022 GMC Sierra 3500HD CarBuzz
-
Mini Gives First Electric Car A Name CarBuzz
-
Nose Popping Sound
-
Lol Zac Wiki
-
The Monk Mod Wiki
-
All Sleep Articles Everyday Health
-
We re both the same level but we re not Disguised Toast discusses interaction with other streamers at TwitchCon partner lounge
-
What was William Byron s moral of our day from NASCAR Talladega race
-
Did Dream lose weight Alleged leaked image resurfaces following face reveal
-
Fabrizio Romano drops huge update on Manchester United s pursuit of England superstar Reports
-
I got to think it s somewhat of a real big issue Chris Simms says serious personal matter is reason for Tom Brady s absence
-
We ll have 3 points We re winning it all Arsenal fans delighted as Arteta drops 30 year old star from squad to face Leicester
-
Arsenal codes in Roblox Free bucks calling card and more August 2022
-
Top AEW star claps back at critics following recent controversy in Tony Khan s promotion
-
Apple has now officially ditched Intel silicon for good TechRadar
-
Intel have now suspended all operations in Russia not just product shipments Rock Paper Shotgun
-
18 Russian Snacks The Rest Of The World Really Needs
-
24 WTF Pictures You ll Have To Look At Not Once But Twice
-
Edwina Ings Chambers Gardeners you ll really dig these YOU Magazine
-
Lale bitkisi
-
Seferi sabah namazı nasıl kılınır